Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Pharmaceutics|April 23, 2022
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse ModelElisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, et al.
Head & Neck|February 2, 2024
Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinomaEster Benaiges, Victòria Ceperuelo-Mallafré, Sandra Guaita, et al.
Oncotarget|September 12, 2015
Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patientsMiguel Angel Pavón, Irene Arroyo-Solera, Marta Téllez-Gabriel, et al.
Head & Neck|October 31, 2015
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinomaMiguel Angel Pavón, Matilde Parreño, Marta Téllez-Gabriel, et al.
Frontiers in Oncology|January 9, 2019
The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer PatientsMiren Taberna, Montserrat Torres, María Alejo, et al.
Human Molecular Genetics|December 20, 2014
Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapyAlbert Ribera, Virginia Haurigot, Miguel Garcia, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre studyLea Schroeder, Paolo Boscolo-Rizzo, Elisa Dal Cin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2026
AAV-mediated FGF21 gene therapy promotes healthspan extension by whole-body tissue-specific adaptationsVeronica Jimenez, Victor Sacristan, Miquel Garcia, et al.
Cancers|April 30, 2021
Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic MarkerXimena Terra, Victoria Ceperuelo-Mallafré, Carla Merma, et al.
Nature Communications|September 10, 2021
Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapyJoan Bertolin, Víctor Sánchez, Albert Ribera, et al.
Pageof 17